A stepwise approach to the management of metastatic midgut carcinoid tumor

Nat Rev Clin Oncol. 2009 Jul;6(7):429-33. doi: 10.1038/nrclinonc.2009.70.

Abstract

Background: A 48-year-old man presented with diarrhea, flushing, abdominal pain and weight loss of 10 kg over a 6-month period. He subsequently developed dyspnea on exertion.

Investigations: Physical examination, laboratory tests, CT of the abdomen, liver biopsy, echocardiography, immunohistochemistry staining of the biopsy specimen for neuroendocrine markers including chromogranin A, synaptophysin and protein gene product 9.5, and (111)In-pentetreotide scintigraphy (Octreoscan).

Diagnosis: Carcinoid tumor of midgut origin with large segment 3 liver metastasis. Carcinoid syndrome and carcinoid heart disease.

Management: Symptomatic relief with somatostatin analog therapy and subsequent resection of the segment 3 liver metastasis. Tricuspid and pulmonary valve replacement.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoid Heart Disease / therapy
  • Carcinoid Tumor / pathology*
  • Carcinoid Tumor / therapy*
  • Chemoembolization, Therapeutic
  • Combined Modality Therapy
  • Delayed-Action Preparations
  • Humans
  • Intestinal Neoplasms / secondary*
  • Intestinal Neoplasms / therapy*
  • Liver Neoplasms / secondary
  • Liver Neoplasms / therapy
  • Male
  • Middle Aged
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use

Substances

  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Somatostatin